Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The use of GLP‐1 receptor agonists in hospitalised patients: An untapped potential
Омар Мустафа, Martin Whyte
Diabetes/Metabolism Research and Reviews (2019) Vol. 35, Iss. 8
Open Access | Times Cited: 23

Showing 23 citing articles:

GLP-1a: Going beyond Traditional Use
Lucas Fornari Laurindo, Sandra Maria Barbalho, Élen Landgraf Guiguer, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 739-739
Open Access | Times Cited: 71
Dissecting the interaction between COVID‐19 and diabetes mellitus
Ying Jie Chee, Seng Kiong Tan, Ester Yeoh
Journal of Diabetes Investigation (2020) Vol. 11, Iss. 5, pp. 1104-1114
Open Access | Times Cited: 76
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Exploring Their Impact on Diabetes, Obesity, and Cardiovascular Health Through a Comprehensive Literature Review
Khalid M Hamed, Mohammed N Alosaimi, Bashaer A Ali, et al.
Cureus (2024)
Open Access | Times Cited: 7
Preoperative considerations of new long-acting glucagon-like peptide-1 receptor agonists in diabetes mellitus
Abraham H. Hulst, Jorinde A. W. Polderman, Sarah E. Siegelaar, et al.
British Journal of Anaesthesia (2020) Vol. 126, Iss. 3, pp. 567-571
Open Access | Times Cited: 49
Perspectives of Antidiabetic Drugs in Diabetes With Coronavirus Infections
Bao Sun, Shiqiong Huang, Jiecan Zhou
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 34
Safety and Efficacy of Inpatient Diabetes Management with Non-insulin Agents: an Overview of International Practices
Rodolfo J. Galindo, Ketan Dhatariya, Fernando Gómez-Peralta, et al.
Current Diabetes Reports (2022) Vol. 22, Iss. 6, pp. 237-246
Open Access | Times Cited: 23
The use of sodium‐glucose co‐transporter 2 inhibitors in the inpatient setting: Is the risk worth taking?
Theocharis Koufakis, Омар Мустафа, Ramzi Ajjan, et al.
Journal of Clinical Pharmacy and Therapeutics (2020) Vol. 45, Iss. 5, pp. 883-891
Open Access | Times Cited: 34
COVID-19 and Diabetes: A Comprehensive Review of Angiotensin Converting Enzyme 2, Mutual Effects and Pharmacotherapy
Lingli Xie, Ziying Zhang, Qian Wang, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 23
GLP-1 receptor agonists and cardiovascular disease: drug-specific or class effects?
Elric Zweck, Michael Roden
The Lancet Diabetes & Endocrinology (2019) Vol. 7, Iss. 2, pp. 89-90
Open Access | Times Cited: 25
Therapy of Type 2 Diabetes in Patients with SARS-CoV-2 Infection
Weronika Bielka, Agnieszka Przezak, Andrzej Pawlik
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7605-7605
Open Access | Times Cited: 20
Bridging the gap in cardiovascular care in diabetic patients: are cardioprotective antihyperglycemic agents underutilized?
André Scheen
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 11, pp. 1053-1062
Closed Access | Times Cited: 8
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Luping Wang, Hao Yang, Xiaoxiao Xia, et al.
Critical Care (2024) Vol. 28, Iss. 1
Open Access | Times Cited: 2
GLP‐1 RA and atrial fibrillation in the cardiovascular outcome trials
Zahra Hamedi, Basem M. Mishriky, Victor Okunrintemi, et al.
Diabetes/Metabolism Research and Reviews (2021) Vol. 37, Iss. 5
Closed Access | Times Cited: 14
How to Increase Muscle Mass in Critically Ill Patients: Lessons Learned from Athletes and Bodybuilders
Khushboo Gala, Viral Desai, Nanlong Liu, et al.
Current Nutrition Reports (2020) Vol. 9, Iss. 4, pp. 369-380
Closed Access | Times Cited: 11
Clinical progress note: Glucagon‐like peptide‐1 receptor agonists and hospitalized patients
Anjali Ravee, Desirée C Burroughs‐Ray, Christopher Jackson, et al.
Journal of Hospital Medicine (2024) Vol. 19, Iss. 8, pp. 716-719
Closed Access | Times Cited: 1
Variabilidad glucémica tras trombectomía mecánica en el ictus isquémico agudo de la circulación anterior
Antônio Carlos Vieira Cabral, André Carvalho, Pedro Barros, et al.
Revista de Neurología (2024) Vol. 79, Iss. 01, pp. 1-1
Closed Access | Times Cited: 1
Control hospitalario de la diabetes y de la hiperglucemia: una auditoría en hospitales españoles
Javier Ena, Juana Carretero Gómez, José Manuel Casas Rojo, et al.
Revista Clínica Española (2023) Vol. 223, Iss. 7, pp. 387-395
Open Access | Times Cited: 3
Retrospective Analysis of Hospitalized Patients with Type 2 Diabetes Mellitus Treated with Glucagon-Like Peptide 1 Receptor Agonist Therapy
Khaingthazin San, Joshua Fogel, Dmitriy Khazron
Southern Medical Journal (2023) Vol. 116, Iss. 2, pp. 231-236
Closed Access | Times Cited: 1
Inpatient management of diabetes and hyperglycaemia: an audit of Spanish hospitals
Javier Ena, Juana Carretero Gómez, José Manuel Casas Rojo, et al.
Revista Clínica Española (English Edition) (2023) Vol. 223, Iss. 7, pp. 387-395
Open Access | Times Cited: 1
Antidiabéticos Não Insulínicos na Abordagem da Hiperglicemia nos Doentes Hospitalizados por Doença Aguda Não Crítica
Sofia Lopes, Ariana Maia, Pedro Melo, et al.
Acta Médica Portuguesa (2024) Vol. 37, Iss. 3, pp. 207-214
Open Access
GLP‐1 receptor agonist use during hospitalisation: Better glycaemic control compared to premixed insulin
Morgan Jervis, Antonine Pineau Mitchell, Nafseen Islam, et al.
Diabetes/Metabolism Research and Reviews (2022) Vol. 38, Iss. 8
Closed Access | Times Cited: 2
Weight Loss Effects of Glucagon-Like Peptide-One Receptor Analog Treatment in a Severely Obese Patient During Hospital Admission
Yaiseli Figueredo, Claudia Cottone, Tanira Ferreira, et al.
Cureus (2023)
Open Access
Non-insulin therapy in diabetic inpatients: SGLT2- inhibitors and incretins for the care of hospitalized patients
G. Brunori
The Journal of AMD (2022) Vol. 25, Iss. 3, pp. 150-150
Open Access
Page 1

Scroll to top